GLP-1 is a peptide hormone that helps regulate blood sugar levels and appetite, commonly used in the management of type 2 diabetes and obesity.
Overview
GLP-1 is an incretin hormone naturally secreted by the gut in response to food intake. It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes a feeling of fullness, making it highly effective for controlling blood glucose and body weight.
Synthetic GLP-1 analogs are formulated for medical use, especially in patients with type 2 diabetes or obesity. The 5mg/vial form is typically administered through subcutaneous injection and offers potent appetite-suppressing and glucose-lowering effects.
Research
Clinical studies have shown that GLP-1 analogs significantly reduce HbA1c levels, support weight loss, and lower the risk of cardiovascular events in diabetic patients. Their dual impact on glucose control and appetite regulation has made them a central part of modern diabetes therapy.
Ongoing research is expanding GLP-1’s applications to include neuroprotection, fatty liver disease management, and even addiction control. Its extended benefits beyond glycemic control continue to generate interest in both medical and wellness communities.
Reviews
There are no reviews yet.